 Cambridge, Massachusetts, Jan. 10, 2022 GLOBE NEWSWIRE -- Summit Therapeutics Inc. NASDAQ: SMMT Summit or the Company reminds interested stakeholders that it will today present the Companys vision and its intended future development pathways at the 40th Annual J.P. Morgan Healthcare Conference at approximately 3:45 PM EST. Robert W. Duggan, Chairman and Chief Executive Officer, and Dr. Maky Zanganeh, Chief Operating Officer and a member of Summits Board of Directors, will provide details regarding Summits current plans with respect to its future research and clinical development goals. 